Dr. Jou, Yuh-Shan 周玉山 博士
| 1. | Chen KJ, Huang JH, Shih JH, Gu DL, Lee SS, Shen R, Hsu YH, Kung YC, Wu CY, Ho CM, Jen HW, Lee HY, Lang YD, Hsiao CH, Jou YS Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma. Molecular carcinogenesis (2023) [JCR] [WOS] |
| 2. | Wang YW, Chen SC, Gu DL, Yeh YC, Tsai JJ, Yang KT, Jou YS, Chou TY, Tang TK A novel HIF1alpha-STIL-FOXM1 axis regulates tumor metastasis. Journal of biomedical science 29(1), 24 (2022) [JCR] [WOS] |
| 3. | Chen HY, Chan SJ, Liu X, Wei AC, Jian RI, Huang KW, Lang YD, Shih JH, Liao CC, Luan CL, Kao YT, Chiang SY, Hsiao PW, Jou YS, Chen Y, Chen RH Long noncoding RNA Smyca coactivates TGF-beta/Smad and Myc pathways to drive tumor progression. Journal of hematology & oncology 15(1), 85 (2022) [JCR] [WOS] |
| 4. | Ho CM, Lin KT, Shen R, Gu DL, Lee SS, Su WH, Jou YS Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma. Computational and structural biotechnology journal 20, 1752-1763 (2022) [JCR] [WOS] |
| 5. | Lang YD, Jou YS PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression. Journal of biomedical science 28(1), 57 (2021) [JCR] [WOS] |
| 6. | Jen Hsin-Wei, Gu De-Leung, Lang Yaw-Dong, Jou Yuh-Shan PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility Cells 9(6), 1490 (2020-06) [JCR] [WOS] |
| 7. | Shih JH, Chen HY, Lin SC, Yeh YC, Shen R, Lang YD, Wu DC, Chen CY, Chen RH, Chou TY, Jou YS* Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma. Nucleic acids research 48(3),1175-1191 (2020-02) [JCR] [WOS] |
| 8. | Lang Yaw-Dong, Jou Yuh-Shan PSPC1: a contextual determinant of tumor progression Molecular & Cellular Oncology 7(2), 1721253 (2020-02) [JCR] [WOS] |
| 9. | Lang YD, Chen HY, Ho CM, Shih JH, Hsu EC, Shen R, Lee YC, Chen JW, Wu CY, Yeh HW, Chen RH, Jou YS* PSPC1-interchanged interactions with PTK6 and beta-catenin synergize oncogenic subcellular translocations and tumor progression. Nature communications 10(1), 5716 (2019-12) [JCR] [WOS] |
| 10. | Yeh HW, Lee SS, Chang CY, Lang YD, Jou YS* A New Switch for TGFbeta in Cancer. Cancer research 79(15), 3797-3805 (2019-08) [JCR] [WOS] |
| Record 1 to 10, total of 87 records |